2024 Pharm Exec Top 50 Companies
Jun 14, 2024 · As we noted in last year’s report, Novo Nordisk and Eli Lilly, competing in the lucrative GLP-1 receptor agonist space that, of late, has captivated the US and beyond in weight loss, are knocking loudly on the top-10 door.Both companies, who own the highest market caps, respectively, in pharma, turned in massive growth in our latest Pharma 50.
Pharmaceutical Executive
Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.
Financial Times Global Pharma and Biotech Summit: The Impact of …
Nov 7, 2024 · Donald Trump’s victory in the 2024 US presidential election is sure to have an impact on the pharmaceutical industry. During a panel at the Financial Times’ 2024 Global Pharma and Biotech Summit, the following speakers met to discuss the outcome of the election and the impact it may have on the industry: Lauren Fedor, US political correspondent and Washington deputy bureau chief at The ...
2024’s Executive Profiles - pharmexec.com
Dec 25, 2024 · In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Pharma Marketing Trends to Expect in 2025 - pharmexec.com
Oct 22, 2024 · In a recent video interview with Pharmaceutical Executive, Amanda Powers-Han, Chief Marketing Officer, Greater Than One and Pharmaceutical Executive Advisory Board Member discussed the importance of patient engagement in pharma marketing. She emphasized the need for personalized marketing strategies that build trust and ensure data privacy. The use of AI and advanced analytics tools was ...
Pharmaceutical Executive - PharmExec
Master the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.
Pharma Marketing's Top Movers and Shakers in 2024
Dec 20, 2024 · The pharmaceutical industry is undergoing a transformative era, driven by groundbreaking advancements in technology, shifting consumer expectations, and an intensified focus on personalized healthcare solutions.
2024 Apex Awards Winners - pharmexec.com
Company: Elevar Therapeutics Agency: The Agency Network at MJH LifeSciences Campaign: Elevar uHCC Disease Awareness Campaign
Advantages & Disadvantages of Using Compounded Medications
Oct 24, 2024 · Scott Brunner, CEO, and Tenille Davis, Chief Advocacy Officer, of the Alliance for Pharmacy Compounding discuss how compounded medications differ from commercially available drugs in terms of their manufacturing process, quality standards, and more.
FDA Approves Hikma’s Generic GLP-1 Agonist for Type 2 Diabetes
Dec 24, 2024 · The FDA has approved Hikma Pharmaceuticals’ generic referencing Victoza (liraglutide injection) 18 milligram/3 milliliter, a glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes as an adjunct to diet and exercise.